Ignite Creation Date:
2025-12-24 @ 7:17 PM
Ignite Modification Date:
2025-12-25 @ 4:55 PM
Study NCT ID:
NCT04657003
Status:
COMPLETED
Last Update Posted:
2024-04-08
First Post:
2020-12-01
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-29
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-04-10
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-01
First Submit QC Date:
None
Study First Post Date:
2020-12-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-03-08
Results First Submit QC Date:
None
Results First Post Date:
2024-04-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-08
Last Update Post Date:
2024-04-08
Last Update Post Date Type:
ACTUAL